Article
Efficacy and safety of minodronate in the treatment of postmenopausal osteoporosis with low back pain: a single-centre and randomized controlled trial
2023-01-16
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Low back pain is one of the most common symptoms of osteoporosis (OP). The pain can seriously affect patients' mood and quality of life; it can also further aggravate bone loss, causing a serious social burden. Minodronate is a third-generation bisphosphonate. Daily oral administration of minodronate significantly reduces levels of bone resorption markers and ra...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2b65a898-5436-59db-9488-78a069f1e352
- DOI
- 10.21203/rs.3.rs-2230027/v1
